Review Article

Adjuvant Treatment of Melanoma

Table 8

Final results of study EORTC 18961 [26].

RFS DMFS OS
OBSGM2-KLH/QS-21OBSGM2-KLH/QS-21OBSGM2-KLH/QS-21

No. of events204205143152112124
4 yr% (SE%)69.4% (1.9%)68.2% (1.9%)78.8% (1.7%)76.1% (1.8%)83.6% (1.6%)81.5% (1.6%)
HR (95% CI)*1.03 (0.84, 1.25)1.11 (0.88, 1.40)1.16 (0.90, 1.51)
P value*0.810.360.26

HR: hazard ratio. *Cox model: stratified for stratification factors. OBS: observation. RFS: relapse-free survival. DMFS: distant metastasis-free survival.
OS: overall survival.